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INTRODUCTION
The purpose of total-body irradiation (TBI) and allo-
geneic marrow transplantation for the therapy of patients
with leukemia is to deliver the greatest antileukemic and
immunosuppressive effects with the least toxicity to non-
hematopoietic organs. Variables influencing the effect of TBI
include total radiation dose, dose rate, and fractionation. The
issue of dose rate effects on hematopoietic cells has been
controversial. Some investigators have concluded that
increasing the dose rate increases the death rate of hemato-
poietic cells at a given total dose of TBI [1–3], although for
smaller total doses (e.g., 200 cGy), it has been assumed that
there is little dose-rate effect because most cell killing would
be effected by single-hit mechanisms [4]. Other investigators
maintain that there are no significant differences in radiation
sensitivity of hematopoietic cells at different dose rates [5–9].
The issue of dose fractionation of TBI has also been
controversial. Some investigators have advanced the concept
that hematopoietic cells have a lessened ability for DNA
repair in interfraction intervals than cells from other organs,
and that the effect on the marrow would be similar for a
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ABSTRACT
We evaluated the marrow toxicity of 200 and 300 cGy total-body irradiation (TBI) delivered at 10 and 60 cGy/min,
respectively, in dogs not rescued by marrow transplant. Additionally, we compared toxicities after 300 cGy fraction-
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on the basis of peripheral blood cell count changes and mortality from radiation-induced pancytopenia. TBI doses
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cGy each (n510). Within the limitations of the experimental design, three conclusions were drawn: 1) with 200 and
300 cGy single-dose TBI, an increase of dose rate from 10 to 60 cGy/min, respectively, caused significant increases
in marrow toxicity; 2) at 60 cGy/min, dose fractionation resulted in a significant decrease in marrow toxicities,
whereas such a protective effect was not seen at 10 cGy/min; and 3) with fractionated TBI, no significant differences
in marrow toxicity were seen between dogs irradiated at 60 and 10 cGy/min. The reduced effectiveness of TBI
when a dose of 300 cGy was divided into three fractions of 100 cGy or when dose rate was reduced from 60
cGy/min to 10 cGy/min was consistent with models of radiation toxicity that allow for repair of sublethal injury in
DNA.
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given total dose of single-dose or fractionated TBI [10–15].
Others have disputed this view and have presented data to
the effect that malignant and nonmalignant hematopoietic
cells have greater repair capacity than previously thought and
believe that a single dose of TBI delivered at the relatively
high dose rate of 26 cGy may achieve better leukemic cell
kill than fractionated TBI [16–18]. The controversy may be
related to the mixture of different cell types that make up the
hematopoietic system, which have a wide range of radiation
sensitivities, and to different experimental readouts depend-
ing on which cells were studied for irradiation effects.
Given the controversies, it is not surprising that a wide
spectrum of TBI conditioning programs has been developed
clinically. Programs range from single-dose 500 cGy at 50
cGy/min to almost 1600 cGy at 6–7 cGy/min given in seven
fractions over 7 days [19–23]. Other regimens have included
hyperfractionation with up to 12 fractions administered over
3 days [24].
Early attempts at mathematical description of how deliv-
ery method affects the potency of a radiation dose focused
either on varying dose rate for a single, continuous exposure
or on varying the number and separation of fractions given
in acute bursts. Nilsson et al. [25] generalized from these
models and developed an equation describing the surviving
fraction of a cell population exposed to radiation when there
is exponential repair of sublethally damaged cells both dur-
ing and between radiation fractions. In their model, the
effect of a given dose of radiation depends on the number of
fractions, the exposure time for each fraction, and the inter-
fraction interval. It follows from their mathematical expres-
sion that switching from a single session to a fractionated
delivery schedule boosts cell survival most when radiation is
given in acute bursts. As the dose rate decreases, fractiona-
tion yields diminishing gain in cell survival for the same total
dose [25,26]. Presumably, during the relatively long exposure
times needed to deliver single-dose TBI at low dose rates,
the “four R’s of radiobiology” [14], reassortment, repopula-
tion, reoxygenation, and recovery (DNA repair), become
operative, perhaps changing the radiosensitivity of cells. 
We have addressed many of the issues associated with
TBI in dogs with the aim of developing clinically applicable
TBI programs [27–34]. Initial studies were all done with
dose rates of ≤10 cGy/min. The marrow-lethal single dose
was found to be 400 cGy [27]. When we compared the mar-
row-toxic effects of single-dose vs. fractionated TBI with
total doses ranging from 200 to 600 cGy, we could find no
statistically significant differences in the marrow toxicity
between the two modes of radiation, even when dogs were
treated with canine recombinant granulocyte colony-stimu-
lating factor (rG-CSF) after TBI [27]. 
Given the previous findings, the current study explored
marrow toxicity of fractionated vs. single-dose TBI deliv-
ered at the relatively high dose rate of 60 cGy/min. Total
TBI doses of 200 and 300 cGy were studied in dogs not
given marrow infusions, and results were compared with
those at a dose rate of 10 cGy/min. 
MATERIALS AND METHODS
Beagles and hound/beagle and beagle/harrier cross-
breeds were raised at the Fred Hutchinson Cancer Research
Center or purchased from commercial kennels in Washing-
ton State. The dogs weighed 6.2–19.7 kg (median 9.9) and
were 5.5–17.5 months of age (median 7.8). They were
observed for disease for at least 2 months before TBI. All
were immunized for leptospirosis, hepatitis, distemper, and
parvovirus. Research was carried out according to the prin-
ciples in the Guide for Laboratory Animal Facilities and Care
prepared by the National Academy of Sciences, National
Research Council. The research protocol was approved by
the Institutional Animal Care and Use Committee of the
Fred Hutchinson Cancer Research Center.
TBI was administered to the unanesthetized dogs
housed in a polyurethane cage placed transversely midway
between two opposing 60Co sources as previously described
[27,32,33]. Beam intensity over the entire cross-sectional
area of the cage was .90% of the central axis intensity.
The dose rate in air at the midpoint of the cage was deter-
mined with a 0.6 cm3 ionization chamber (Keithley Instru-
ments, Cleveland, OH) and an electrometer system (Keith-
ley Instruments). The midplane tissue absorbed dose in
grays, as measured by implanted lithium fluoride thermo-
luminescent dosimeters, was numerically ~76% of the
exposure in air at the center of the cage measured in roent-
gens. The midplane dose rate was either 10 or 60
cGy/min. The thermoluminescent dosimeters contained
lithium fluoride phosphor in disks (Teflon) and were meas-
ured with a reader (Teledyne Isotopes, Westwood, NJ) cal-
ibrated over a range of 1–50 Gy. Results in dogs given 300
cGy single-dose TBI were compared with those in dogs
given 300 cGy TBI administered in three 100-cGy frac-
tions. The time elapsed from the first to the third fraction
was ≤20 hours, with the first fraction separated from the
second by a minimum of 6 hours. 
Dogs were given oral neomycin sulfate and polymyxin
B sulfate three times a day beginning 5 days before TBI
through the day after transplant at which granulocyte
counts reached 500/mm3 [35]. Additionally, they were
treated twice a day with systemic ceftazidime until granu-
locyte recovery. Platelet transfusions from unrelated
donors were given when platelet counts fell  to
,5000/mm3. Hemorrhage was not a serious problem in
the study. All transfusions were irradiated in vitro with
2000 cGy from a 137Ce source to inactivate lymphocytes.
Complete peripheral blood cell counts, including white
blood cell differentials, were obtained daily between 8 and
9 a.m. All dogs that died or were killed with sodium pento-
barbital had complete autopsies with histologic examina-
tion of autopsy specimens.
We assessed the marrow toxicity of each treatment on
the basis of survival and individual dogs’ peripheral blood
granulocyte and platelet count changes through time after
TBI. All tests concerning proportions of dogs that survived
with complete hematologic recovery were conducted using
small-sample testing procedures based on Monte Carlo sim-
ulation [36]. Blood counts were summarized by plotting
median counts among surviving dogs. Group medians were
calculated only while at least three dogs survived in the
group, and medians were connected in the plots using a
spline smoothing technique with Stata statistical software
[37]. We tested for differences between groups in the nadir
blood counts using Wilcoxon rank-sum tests. 
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RESULTS
Tables 1 and 2 and Figures 1–3 summarize the results.
Data on the 44 dogs that received TBI at 10 (n535) or 7
(n59) cGy/min have been published previously [27] and are
presented here for purposes of comparison.
Five dogs were given a single dose of 200 cGy TBI
delivered at 60 cGy/min. Their peripheral blood platelet
and granulocyte counts showed significantly lower nadirs (p
5 0.01 and 0.02, respectively) than those of 13 dogs given
200 cGy TBI at 10 cGy/min (Fig. 1). Lymphocyte counts
also declined more in dogs given TBI at the higher dose
rate, although the difference did not reach statistical signifi-
cance (p 5 0.055). Four of the five dogs given 200 cGy at 60
cGy/min survived, compared with 12 of 13 given the same
dose of TBI at 10 cGy/min, a difference that was not statis-
tically significant. Fractionated TBI was not studied at 200
cGy because of the almost uniform survival of dogs given
single-dose TBI, regardless of the dose rates studied.
Forty-six dogs were given 300 cGy TBI. The dose of
300 cGy was deemed to be most informative, since previous
studies had shown it not to be uniformly lethal (30% [single
dose] and 60% [fractionated dose] of dogs so treated sur-
vived), while after 400 cGy, virtually all dogs (27 of 28) died
[27]. In 21 of the dogs given 300 cGy, single-dose TBI was
administered at low dose rates (10 cGy/min, n=12; 7
cGy/min, n=9), and in five dogs it was administered at 60
cGy/min. Seven of the 21 dogs given single-dose TBI at a
low dose rate survived, compared with none of five given
single-dose TBI at 60 cGy/min, a result that was not signifi-
cantly different (p 5 0.14). 
Twenty dogs received 300 cGy fractionated TBI. Six of
10 dogs given TBI at 10 cGy/min survived compared with
seven of 10 at 60 cGy/min (p 5 0.82). When comparing
survival of dogs given single-dose TBI at 10 cGy/min to
that of dogs given fractionated TBI at 10 cGy/min, no
significant difference emerged (p 5 0.18). Dogs given frac-
tionated TBI at 60 cGy/min, however, had significantly
better survival than those given single-dose TBI at 60
cGy/min (p 5 0.01). 
Table 1. Marrow toxicity of total body irradiation (TBI) given at 10 vs. 60
cGy/min
Total TBI Dose rate Dogs surviving/dogs studied
dose (cGy) (cGy/min) Single dose Fractionated
200* 10 12/13† —
200 60 4/5 —
300* 10‡ 7/21 6/10
300 60 0/5 7/10
p values derived from Monte Carlo simulation tests.
*Data on these dogs previously published [16].
†p = 0.53 vs. dogs given a single dose of 200 cGy at 60 cGy/min.
‡Nine of the 21 dogs received 7 cGy/min; six of those nine died compared with
eight of 12 receiving 10 cGy/min.
Table 2. Dogs given 200 or 300 cGy total body irradiation from two opposing 60Co sources, delivered at 60 cGy/min in a single dose or three fractions of 100 cGy
each over 2 days with <6-hour interfraction intervals
Granulocyte Marrow cellularity 
Total Mode of Dose rate recovery after at autopsy Survival Cause of 
Dog no. dose (cGy) radiation (cGy/min) postirradiation nadir (% normal) (days)* death
D273 200 Single dose 60 Yes 100 65‡ Killed†
D286 Yes 100 77‡ Killed†
D348 Yes 100 64‡ Killed†
D349 Yes 100 63‡ Killed†
D325 No ,5 19 Septicemia
D203 300 Single dose 60 No ,5 18 Pneumonia
D344 No 0 20 Septicemia
D408 No 0 17 Septicemia
D409 No 0 19 Pneumonia
D421 No ,5 20 Septicemia
D378 300 33100 cGy 60 Yes 100 56‡ Killed†
D404 Yes 100 50‡ Killed†
D410 Yes 80 53‡ Killed†
D511 No 0 22 Septicemia
D517 Yes 100 40‡ Killed†
D521 No ,5 18 Septicemia
D523 Yes 100 60‡ Killed†
D531 Yes 100 75‡ Killed†
D533 No ,5 17 Septicemia
D538 Yes 100 72‡ Killed†
Dogs were not given marrow infusions. 
*Measured from time of last irradiation. 
†Killed with intravenous injection of sodium pentobarbital at the completion of the experiment. 
‡Dogs that survived with complete hematological recovery after TBI.
p = 0.53‡
p = 0.18
p = 0.14 p = 0.82
p = 0.013
4
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In addition to the preceding pairwise comparisons, we
performed a Monte Carlo simulation test to determine
whether the factor by which survival differed between sin-
gle and fractionated modes of TBI delivery was the same at
both 10 and 60 cGy/min. The result indicated that dose
rate had a significant impact on the differential between
effects of single and fractionated TBI (p 5 0.03), the
greater difference in survival occurring when the dose rate
was 60 cGy/min.
In dogs given 300 cGy single-dose or fractionated TBI,
there were strong indications that postirradiation platelet
counts fell to lower levels when the dose rate was 60
cGy/min compared with 10 cGy/min (p 5 0.06 single; p 5
0.03 fractionated) (Fig. 2). Granulocyte counts dropped very
low for dogs in all four groups receiving 300 cGy (Fig. 3).
There were no significant differences between granulocyte
nadirs from dogs irradiated at 10 vs. 60 cGy/min, with
either single-dose or fractionated TBI. Among dogs given
irradiation at 60 cGy/min, however, there was a weak sug-
gestion that those given single-dose TBI had lower periph-
eral blood granulocyte nadirs than those given fractionated
TBI (p 5 0.13), and the slope of the granulocyte counts in
dogs given single-dose TBI showed a significantly faster
decline (p 5 0.03). Regular daily peripheral blood counts
were not available for the nine dogs given 300 cGy at 7
cGy/min, so data from those animals could not be included
in the analyses of count nadirs.
DISCUSSION
The present study evaluated marrow toxicity of single-
dose vs. fractionated-dose TBI, delivered at the relatively
high dose rate of 60 cGy/min, based primarily on the crite-
ria of granulocyte and platelet changes and survival. Dogs
that died from marrow toxicity uniformly succumbed to
infections despite prophylaxis and treatment with oral and
systemic broad-spectrum antibiotics, infections presumably
being the direct result of the extent and duration of the radi-
ation-induced granulocytopenia. Thus, these results will
have to be viewed with the understanding that the model
addressed early radiation responses of a group of marrow
precursor cells that might correspond to murine spleen
colony-forming unit (CFU-S)–like cells. Damage to
pluripotent hematopoietic stem cells was not assessed here.
Using similar study criteria, we previously showed that
single-dose and fractionated TBI delivered at a dose rate of
10 cGy/min had marrow toxicities in this model comparable
to total doses of 200–600 cGy even when dogs were treated
after radiation with canine rG-CSF [27]. These findings fit
well with the concept that sublethal damage repair of
hematopoietic progenitor or stem cells was minimal during
fractionated radiation, with the result that the effects on
marrow of single vs. fractionated TBI delivered at the low
dose rate of 10 cGy/min were equivalent.
Two results emerged from the current study using a rel-
atively high dose rate of 60 cGy/min. First, a single dose of
TBI administered at 60 cGy/min appeared more marrow-
toxic than an equivalent total dose delivered at 10 cGy/min,
as indicated by more profound declines in peripheral blood
cell counts. Survival rates with single-dose delivery also
trended to show greater toxicity at the higher dose rate,
although the differences were not statistically significant.
This result agreed with those from a number of previous
studies in various model systems showing greater organ tox-
icity with higher dose rates [1,3,10–14,38–43]. In dogs, toxi-
city to both gut [34] and lymphoid system [44] increased
significantly when the TBI dose rate was increased by one
log. Interestingly, other studies, using transfer of marrow
cells from irradiated donors into irradiated recipients, found
no significant differences in radiation sensitivity of CFU-S
at different dose rates [5–7,9,45]. In one of those studies,
using day 9 CFU-S as an end point, the investigators irradi-
ated donor mice with TBI doses ranging from 100 to 500
cGy at dose rates of 8, 45, and 103 cGy/min [9]. They then
transplanted femoral marrow into lethally irradiated syn-
geneic recipient mice and found that the numbers of day 9
spleen colonies were identical, regardless of the dose rate
used to irradiate the marrow donors. One possible explana-
tion for the finding might be that the investigators killed
donor mice 24 hours after TBI, flushed the femurs, and
then adjusted the number of transplanted cells to yield
10–20 spleen colonies. This way, the experiment may have
been biased against radiation dose rate–dependent cell death
occurring over the 24 hours after TBI. Perhaps transplanta-
Figure 1. Peripheral blood platelet and granulocyte changes
Median peripheral blood platelet (A) and granulocyte (B) changes in dogs
given a single dose of 200 cGy TBI, delivered at 10 cGy/min (n513) or 60
cGy/min (n55). 1, 10 cGy/min; s, 60 cGy/min.
A
B
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tion of entire femur contents might have been another way
to address the question of dose rate–dependent radiation
toxicity of day 9 CFU-S. Nevertheless, in vitro irradiated
human and animal tumor cell lines also showed dose
rate–independent cell killing for almost all lines except
U937 and HL60 [8].
The second result was not anticipated from the previous
canine study [27]. Fractionated TBI delivered at 60 cGy/min
proved to be no more marrow-toxic than fractionated TBI
delivered at 10 cGy/min, but was significantly less toxic than
single-dose TBI at 60 cGy/min as determined within the lim-
itations of the current end points. Fractionated TBI at 10
Figure 2. Peripheral blood platelet changes
Dogs were given 300 cGy TBI, delivered at 10 cGy/min as a single dose (n510) or in three fractions (n510) or at 60 cGy/min as a single dose (n55) or in three
fractions (n510).
Figure 3. Peripheral blood granulocyte changes
Dogs were given 300 cGy TBI, delivered at 10 cGy/min as a single dose (n510) or in three fractions (n510) or at 60 cGy/min as a single dose (n55) or in three
fractions (n510).
160
cGy/min was not significantly different from single-dose TBI
at 10 cGy/min. These results indicate that the mode of radia-
tion is an important factor in determining marrow toxicity.
The finding is consistent with DNA repair in those early
hematopoietic progenitor or stem cells during interfraction
intervals of high-dose-rate TBI that give rise to hemato-
poietic recovery. Furthermore, by inference, it can be argued
that such DNA repair is possible even during single-dose TBI
whenever the dose rate is low, such as 10 cGy or less. No
direct measurements of surviving fraction of hematopoietic
cell populations were available in the current, clinically ori-
ented experiments. It seems reasonable to expect, however,
that survival probability for the individual dog is closely and
directly linked to surviving fraction of hematopoietic cells.
Our statistical analyses of survival data suggest a different
impact of fractionating the total dose at high vs. low dose
rate. This result parallels the interactions between fractiona-
tion interval and dose rate that are described theoretically in
the generalized incomplete repair model of Nilsson et al. [25].
Current findings at high dose rate (single-dose TBI is
more marrow toxic than fractionated TBI) may help explain
the apparent discrepancy between our previous report (mar-
row toxicity of single-dose TBI at low dose rate equivalent to
that of fractionated TBI) and a report by Down et al. [1] in
congenic strains of mice differing for hemoglobin phenotype.
Consistent with the current findings, those authors reported
that full engraftment of congenic marrow occurred at 700
cGy single-dose TBI given at the high dose rate of 100
cGy/min, while it took 1600 cGy of fractionated TBI at the
same dose rate to achieve the same result. Ploemacher et al.
[17], using mice congenic for the glucose-phosphate iso-
merase gene, extended those observations and found that to
achieve the same level of engraftment seen with 4 Gy single-
dose TBI (dose rate 1.06–1.08 Gy/min), an extra 2 Gy of
fractionated TBI was needed. An earlier murine study had
already pointed out that the LD50–30 days dose of TBI increased
from 650 cGy given as a single fraction to 1200 cGy when
administered as five daily fractions [46]. Our own data on
engraftment of DLA-identical marrows also conclusively
showed that lymphoid cells, responsible for graft rejection,
were capable of DNA repair in interfraction intervals, and
much higher doses of fractionated than of single-dose TBI
were needed for consistent engraftment to occur [28,44].
Taken together, the murine and the current canine data
show that marrow toxicity of fractionated TBI is not always
equivalent to that of single-dose TBI. While extensive pre-
vious data from this laboratory describe no significant dif-
ferences between the two modes of radiation at low dose
rate, the current results at a relatively high dose rate show
that DNA repair in hematopoietic progenitor or stem cells
is possible during interfractionation intervals. Thus, frac-
tionated TBI at higher dose rates may have no advantage for
conditioning marrow graft recipients unless it can be shown
convincingly that the sparing of nonhematopoietic tissues
due to fractionation is significantly greater [31,47] than the
sparing of hematopoietic cells.
ACKNOWLEDGMENTS
The authors are grateful to Eileen Severns, Mimi
Arcand, Cindy David, Jeanine Pazasis, Lee Anderson, and
Greg Davis for technical expertise and to Bonnie Larson,
Harriet Childs, Julie Sentkowski, and Lori Ausburn for sec-
retarial help. We would also like to thank Barbara Johnston,
DVM, and the technicians of the hematology, pathology,
and bacteriology laboratories of the Fred Hutchinson Can-
cer Research Center for their assistance. We also thank Dr.
Rodney Withers, UCLA, for reviewing the manuscript.
REFERENCES 
1 Down JD, Tarbell NJ, Thames HD, Mauch PM: Syngeneic and allo-
geneic bone marrow engraftment after total body irradiation: depen-
dence on dose, dose rate, and fractionation. Blood 77:661, 1991.
2 Steel GG: The dose-rate effect. In: The Biological Basis of Radiothera-
py. GG Steel, GE Adams, A Horwich, Eds. Amsterdam: Elsevier, 223,
1989.
3 Gengozian N, Carlson DE, Allen EM: Transplantation of allogeneic
and xenogeneic (rat) marrow in irradiated mice as affected by radiation
exposure rates. Transplantation 7:259, 1969.
4 Elkind MM: Fractional dose radiotherapy and its relationship to
survival curve shape (Review). Cancer Treat Rev 3:1, 1976.
5 Belletti S, Gallini RE, Magno L: The effects of dose rate on hemato-
poietic stem cells: preliminary results. Int J Radiat Oncol Biol Phys
5:403, 1979.
6 Broerse JJ, Engels AC, Lelieveld P, van Putten LM, Duncan W,
Greene D, Massey JB, Gilbert CJ, Hendry JH, Howard A: The survival of
colony-forming units in mouse bone-marrow after in vivo irradiation
with D-T neutrons, X- and gamma-radiation. Int J Radiat Biol Rel
Studies Phys Chem Med 19:101, 1971.
7 Krebs JS, Jones DC: The LD50 and the survival of bone-marrow
colony-forming cells in mice: effect of rate of exposure to ionizing radi-
ation. Radiat Res 51:374, 1972.
8 Fitzgerald TJ, McKenna M, Kase K, Daugherty C, Rothstein L, Green-
berger JS: Effect of x-irradiation dose rate on the clonogenic survival of
human and experimental animal hematopoietic tumor cell lines: evi-
dence for heterogeneity. Int J Radiat Oncol Biol Phys 12:69, 1986.
9 Glasgow GP, Beetham KL, Mill WB: Dose rate effects on the sur-
vival of normal hematopoietic stem cells of BALB/c mice. Int J Radiat
Oncol Biol Phys 9:557, 1983.
10 Elkind MM. Radiation Research. Amsterdam: Elsevier, 1967.
11 Fowler JF: Fractionation and therapeutic gain. In: The Biological
Basis of Radiotherapy, 2nd ed. GG Steel, GE Adams, A Horwich, Eds.
Amsterdam, Elsevier, 181, 1989.
12 Steel GG, Down JD, Peacock JH, Stephens TC: Dose-rate effects and
the repair of radiation damage. Radiother Oncol 5:321, 1986.
13 Van Den Bogaert W, Horiot J-C, Van Der Schueren E: Radiotherapy
with multiple fractions per day. In: The Biological Basis of Radiotherapy,
2nd ed. GG Steel, GE Adams, A Horwich, Eds. Amsterdam, Elsevier,
209, 1989.
14 Withers HR: The four R’s of radiotherapy. Adv Radiol Biol 5:241,
1975.
15 Peters LJ, Withers HR, Cundiff JH, Dicke KA: Radiobiological con-
siderations in the use of total-body irradiation for bone-marrow trans-
plantation. Radiology 131:243, 1979.
16 Down JD, Ploemacher RE: Transient and permanent engraftment
potential of murine hematopoietic stem cell subsets: differential effects
of host conditioning with gamma radiation and cytotoxic drugs. Exp
Hematol 21:913, 1993.
17 Ploemacher RE, van Os R, van Beurden CA, Down JD: Murine
haemopoietic stem cells with long-term engraftment and marrow
repopulating ability are more resistant to gamma-radiation than are
p g y y
161B B & M T
spleen colony forming cells. Int J Radiat Biol 61:489, 1992.
18 Song CW, Kim TH, Khan FM, Kersey JF, Levitt SM: Radiobiologi-
cal basis of total body irradiation with different dose rate and fractiona-
tion: repair capacity of hemopoietic cells. Int J Radiat Oncol Biol Phys
7:1695, 1981.
19 Messner HA, Curtis JE, Minden MM: The combined use of cytosine
arabinoside, cyclophosphamide, and total body irradiation as prepara-
tive regimen for bone marrow transplantation in patients with AML
and CML. Semin Oncol 12:187, 1985.
20 Clift RA, Buckner CD, Thomas ED, Sanders JE, Stewart PS, Sullivan
KM, McGuffin R, Hersman J, Sale GE, Storb R: Allogeneic marrow
transplantation using fractionated total body irradiation in patients with
acute lymphoblastic leukemia in relapse. Leuk Res 6:401, 1982.
21 Clift RA, Buckner CD, Appelbaum FR, Bryant E, Bearman SI,
Petersen FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill
RS, McDonald GB, Martin P, Meyers J, Sanders J, Singer J, Stewart P,
Sullivan KM, Witherspoon R, Storb R, Hansen JA, Thomas ED: Allogeneic
marrow transplantation in patients with chronic myeloid leukemia in
the chronic phase: a randomized trial of two irradiation regimens.
Blood 77:1660, 1991.
22 Shank B: Techniques of magna-field irradiation. Int J Radiat Oncol
Biol Phys 9:1925, 1983.
23 Shank B: Radiotherapeutic principles of bone marrow transplanta-
tion. In: Bone Marrow Transplantation. SJ Forman, KG Blume, ED
Thomas, Eds. Boston: Blackwell, 96, 1994.
24 Shank B, Hopfan S, Kim JH, Chu FCH, Grossbard E, Kapoor N, Kirk-
patrick D, Dinsmore R, Simpson L, Reid A, Chui C, Mohan R, Finegan D,
O’Reilly RJ: Hyperfractionated total body irradiation for bone marrow
transplantation. I. Early results in leukemia patients. Int J Radiat Oncol
Biol Phys 7:1109, 1981.
25 Nilsson P, Thames HD, Joiner MC: A generalized formulation of the
“incomplete-repair” model for cell survival and tissue response to frac-
tionated low dose-rate irradiation. Int J Radiat Biol 57:127, 1990.
26 Berry RJ: Effects of radiation dose-rate from protracted, continu-
ous irradiation to ultra-high dose-rates from pulsed accelerators. Br
Med Bull 29:44, 1973.
27 Storb R, Raff RF, Graham T, Appelbaum FR, Deeg HJ, Schuening FG,
Shulman H, Pepe M: Marrow toxicity of fractionated versus single dose
total body irradiation is identical in a canine model. Int J Radiat Oncol
Biol Phys 26:275, 1993.
28 Storb R, Raff RF, Appelbaum FR, Graham TC, Schuening FG, Sale G,
Pepe M: Comparison of fractionated to single-dose total body irradia-
tion in conditioning canine littermates for DLA-identical marrow
grafts. Blood 74:1139, 1989.
29 Storb R, Raff RF, Appelbaum FR, Schuening FW, Sandmaier BM,
Graham TC, Thomas ED: What radiation dose for DLA-identical canine
marrow grafts? Blood 72:1300, 1988.
30 Deeg HJ, Storb R, Shulman HM, Weiden PL, Graham TC, Thomas ED:
Engraftment of DLA-nonidentical unrelated canine marrow after high-
dose fractionated total body irradiation. Transplantation 33:443, 1982.
31 Deeg HJ, Storb R, Longton G, Graham TC, Shulman HM, Appelbaum
F, Thomas ED: Single dose or fractionated total body irradiation and
autologous marrow transplantation in dogs: effects of exposure rate,
fraction size and fractionation interval on acute and delayed toxicity. Int
J Radiat Oncol Biol Phys 15:647, 1988.
32 Deeg HJ, Storb R, Weiden PL, Schumacher D, Shulman H, Graham
T, Thomas ED: High-dose total-body irradiation and autologous mar-
row reconstitution in dogs: dose-rate-related acute toxicity and frac-
tionation-dependent long-term survival. Radiat Res 88:385, 1981.
33 Thomas ED, LeBlond R, Graham T, Storb R: Marrow infusions in
dogs given midlethal or lethal irradiation. Radiat Res 41:113, 1970.
34 Storb R, Raff R, Deeg HJ, Graham T, Appelbaum FR, Schuening FG,
Shulman H, Seidel K, Leisenring W: Dose rate-dependent sparing of the
gastrointestinal tract by fractionated total body irradiation in dogs
given marrow autografts. Int J Radiat Oncol Biol Phys 40:961, 1998.
35 Schuening FG, Storb R, Goehle S, Graham TC, Appelbaum FR, Hack-
man R, Souza LM: Effect of recombinant human granulocyte colony-
stimulating factor on hematopoiesis of normal dogs and on hemato-
poietic recovery after otherwise lethal total body irradiation. Blood
74:1308, 1989.
36 Hope ACA: A simplified Monte Carlo significance test procedure. J
Royal Statist Soc Series B 30:582, 1968.
37 STATA (release 3.0), Santa Monica: Computing Resource Center,
1992.
38 Evans RG, Wheatley CL, Nielsen JR: Modification of radiation-
induced damage to bone marrow stem cells by dose rate, dose fractiona-
tion, and prior exposure to cytoxan as judged by the survival of CFUs:
application to bone marrow transplantation (BMT). Int J Radiat Oncol
Biol Phys 14:491, 1988.
39 Fang MZ, Travis EL, Peters LJ, Barkley HT: The effect of continu-
ous versus fractionated low dose rate total body irradiation on bone
marrow and late tissue responses (Abstract). Proceedings of the 34th
Annual Meeting of the Radiation Research Society, Las Vegas, Nevada.
Philadelphia: RRS, 149, 1986.
40 Bierkens JG, Hendry JH, Testa NG: Recovery of the proliferative
and functional integrity of mouse bone marrow in long-term cultures
established after whole-body irradiation at different doses and dose
rates. Exp Hematol 19:81, 1991.
41 Mitchell JB, Bedford JS, Bailey SM: Dose-rate effects in mammalian
cells in culture. III. Comparison of cell killing and cell proliferation
during continuous irradiation for six different cell lines. Radiat Res
79:537, 1979.
42 Wells RL, Bedford JS: Dose-rate effects in mammalian cells. IV.
Repairable and nonrepairable damage in noncycling C3H 10T1/2 cells.
Radiat Res 94:105, 1983.
43 Puro EA, Clark GM: The effect of exposure rate on animal lethality
and spleen colony cell survival. Radiat Res 52:115, 1972.
44 Storb R, Raff RF, Appelbaum FR, Deeg HJ, Graham TC, Schuening
FG, Sale G, Bryant E, Seidel K: Fractionated versus single-dose total
body irradiation at low and high dose rates to condition canine litter-
mates for DLA-identical marrow grafts. Blood 83:3384, 1994.
45 Till JE, McCulloch EA: A direct measurement of the radiation sen-
sitivity of normal mouse bone marrow cells. Radiat Res 14:213, 1961.
46 van Bekkum DW: Foreign bone marrow transplantation following
fractionated whole-body irradiation in mice. In: Radiation Effects in
Physics, Chemistry and Biology. M Ebert, A Howard, Eds. Amsterdam:
Elsevier, 362, 1963.
47 Tarbell NJ, Amato DA, Down JD, Mauch P, Hellman S: Fractiona-
tion and dose rate effects in mice: a model for bone marrow transplan-
tation in man. Int J Radiat Oncol Biol Phys 13:1065, 1987.
